• Lapatinib: From Kinase Potency to Metastasis Assays

  2026-08-26

  Lapatinib and GW572016 provide a powerful framework for connecting EGFR and HER2 inhibition with proliferation, invasion, and angiogenesis phenotypes. This guide shows how to interpret receptor expression, assay potency, and translational relevance without conflating target engagement with therapeutic response.

• Disodium bicinchoninate for Reliable Cell Assays

  2026-08-26

  Learn how Disodium bicinchoninate, SKU C6645, can support aqueous biochemical workflows, protein normalization, and orthogonal interpretation of cell viability and cytotoxicity experiments. The article combines practical assay design, compatibility checks, preparation guidance, and evidence from H2O2-stressed endothelial-cell research.

• Gefitinib in Gastric Cancer Assembloids

  2026-08-25

  Gefitinib (ZD1839) provides a practical probe for EGFR signaling pathway inhibition in patient-derived gastric cancer organoids and assembloids. By comparing matched tumor-only and tumor–stroma cultures, researchers can distinguish direct pathway sensitivity from microenvironment-driven resistance and improve apoptosis, proliferation, and biomarker workflows.

• METTL17 Links Mitochondrial Translation to CRC Ferroptosis

  2026-08-25

  A 2024 Redox Biology study identifies METTL17 as a mitochondrial RNA-modifying regulator that links mitochondrial translation with ferroptosis resistance and colorectal cancer progression. The findings support METTL17 depletion combined with ferroptotic stress as a research strategy, while highlighting mitochondrial gene expression as a potentially actionable layer of cancer biology.

• RIPostC, Ketone Bodies, and Ferroptosis in Stroke

  2026-08-24

  The 2024 ACS Chemical Neuroscience study identifies ketone body-associated suppression of ferroptosis as a mechanism contributing to remote ischemic postconditioning-mediated neuroprotection after ischemic stroke. In rat MCAO models and oxygen-glucose deprivation/reoxygenation-treated HT22 neurons, the authors connect improved energy metabolism with preservation of GPX4, reduced ACSL4 and iron accumulation, lower lipid peroxidation, and protection of mitochondrial cristae.

• Tunicamycin Workflows for ER Stress Research

  2026-08-24

  Tunicamycin is a practical N-glycosylation inhibitor for separating general ER stress from pathway-specific host responses. This workflow-oriented guide connects macrophage inflammation assays with the HAX1-dependent SARS-CoV-2 spike response while emphasizing controls, dosing logic, and troubleshooting.

• Toremifene Citrate: Research Workflow Guide

  2026-08-23

  Build more interpretable estrogen receptor assays with Toremifene Citrate by combining concentration-response design, vehicle control, receptor-context validation, and translational awareness. This workflow distinguishes receptor-proximal activity from delayed antiproliferative effects and shows when comparison with tamoxifen strengthens breast cancer research.

• Coumestrol: ER Antagonism and RA Ferroptosis

  2026-08-22

  Coumestrol is a phytoestrogen estrogen receptor antagonist and selective estrogen receptor modulator research compound with nanomolar ERα and ERβ antagonist activity. In a rheumatoid arthritis fibroblast-like synoviocyte model, it suppressed inflammatory behavior and promoted PMAIP1-associated ferroptosis, while product data also support broader nuclear receptor modulation.

• Dual Recombinase Tracing Tests Mouse Neo-Oogenesis

  2026-08-22

  Xie, Zhou, and Zheng combine Cre-loxP and Dre-rox lineage tracing to test whether postnatal ovarian cells generate new oocytes in vivo. Across physiological aging and busulfan-induced ovarian injury, the study detected no labeled growing oocytes or metaphase II eggs, strengthening the case that mouse ovarian follicle reserves are not replenished after birth.

• Toremifene Citrate: ER Modulation Guide

  2026-08-21

  Toremifene Citrate is an oral selective estrogen receptor modulator for estrogen receptor signaling and breast cancer research. Its receptor-binding profile, translational evidence, and defined handling parameters support controlled studies of hormone receptor modulation.

• Liproxstatin-1: Ferroptosis Inhibitor Guide

  2026-08-20

  Liproxstatin-1 is a small-molecule ferroptosis inhibitor that suppresses RSL3-induced death with a reported IC50 of 22 nM in primary human proximal tubule epithelial cells. Its reported activity includes inhibition of lipid peroxidation, GPX4-deficient cell protection, and survival extension in a conditional Gpx4-loss mouse model.

• Toremifene Citrate: Evidence, Mechanism, and Use

  2026-08-20

  The reference article presents toremifene citrate as a nonsteroidal antiestrogen and oral selective estrogen receptor modulator for postmenopausal patients with hormone receptor-positive or unknown-status advanced breast cancer. Its practical contribution is a clinically focused synthesis linking estrogen receptor activity, comparative efficacy with tamoxifen, pharmacokinetics, safety monitoring, and the important limitation of cross-resistance.

• Dacomitinib Beyond Blockade: A Ferroptosis Hypothesis

  2026-08-19

  Dacomitinib (PF-00299804) offers translational researchers a way to study sustained pan-HER signaling inhibition while developing a testable hypothesis around mitochondrial ferroptosis defenses, METTL17 biology, and treatment resistance.

• Estradiol: A Practical Guide to ER Signaling Assays

  2026-08-19

  Use Estradiol to model receptor-dependent transcription, autophagy, fibrosis-related responses, and tissue-protective signaling in a controlled experimental workflow. This guide translates recent multi-organ findings into practical dosing, controls, readouts, and troubleshooting strategies for cell and translational research.

• JIB-04 Targets Colorectal Cancer Stem Cells

  2026-08-18

  The reference study identifies JIB-04 as a small-molecule inhibitor that preferentially impairs colorectal cancer stem-cell phenotypes, including self-renewal, tumorsphere formation, invasion, and tumorigenicity. Integrated transcriptomic and reporter assays connect these effects to reduced Wnt/β-catenin signaling, while the study also highlights the need to distinguish functional anti-cancer stem-cell activity from precise molecular target assignment.

7672 records 1/512 page Next 12345 下5页 Last page